The biggest trend observed in recent years in relation to medical contrast media across the health care is doing more with less or maximizing the utility of the existing technology. The companies, such as Bayer Healthcare, Bracco, and GE Healthcare, have established well upon improved contrast media, particularly for CT and MRI. In the recent years, there have been several issues identified about the deposition of gadolinium in the brain and the body causing many side effects, such as formation of nephrogenic systemic fibrosis (NSF) in the kidneys. However, these controversies have led to the research of new mode of contrast media use from contrast media injectors. One of the major concerns among radiologists is still the perceived risk of radiation from medical imaging, with evidence of many patients avoiding indication related imaging to avoid radiation. In many cancer types, it is realized that the use of high-dose radiation was the cause behind it. However, there are some associations, such as American Association of Physicists in Medicine, which stated that there is no evidence that radiation <100 mGy causes increased cancer incidence or mortality.

1. INTRODUCTION 

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY 

4. MARKET DYNAMICS 

5. MARKET SEGMENTATION 

6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE 

7. COMPANY SHARE ANALYSIS

8. MARKET OPPORTUNITIES AND FUTURE TRENDS